Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveRBC Capital Raises Verastem Price Target to $19 From $14

Live News EQUITY FLASH L impact Oct 15, 2026, 10:47 PM UTC

RBC Capital Raises Verastem Price Target to $19 From $14

RBC Capital maintained its Outperform rating on Verastem.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

VSTM

Related stories

Telekom Austria Q3 Revenue Rises 4.6% Year Over Year M impact | EQUITY | Oct 20, 2026, 04:02 PM UTC EssilorLuxottica Reports Latin America Third-Quarter Revenue of EUR415M M impact | EQUITY | Oct 20, 2026, 04:02 PM UTC EssilorLuxottica Reports EUR979M in Third-Quarter Asia-Pacific Revenue EssilorLuxottica reported EUR979 million in revenue from Asia-Pacific for the third quarter. M impact | EQUITY | Oct 20, 2026, 04:02 PM UTC EssilorLuxottica Q3 Revenue Reaches €7.49 Billion, Beats Consensus M impact | EQUITY | Oct 20, 2026, 04:01 PM UTC EssilorLuxottica Reports Third-Quarter Direct-to-Consumer Revenue of EUR 4.09B M impact | EQUITY | Oct 20, 2026, 04:01 PM UTC Lycia Therapeutics Plans IPO of 14.7 Million Shares at $16–$18 Each Lycia Therapeutics said it plans to sell 14.7 million shares in its initial public offering at $16 to $18 each. At the $17 midpoint, the company expects net proceeds of about $2… M impact | EQUITY | Oct 20, 2026, 04:00 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.